Director Business Development, Value and Access

The Director, Business Development, within our Value and Evidence (V&E) team is responsible for positioning and selling Red Nucleus’ full suite Value, Access, Pricing and Evidence solutions to pharmaceutical and biotechnology clients. This role is an individual contributor focused on new business generation, account expansion, and advancement of strategic client relationships with Market Access, Value and Evidence leaders within the pharmaceutical and biotechnology industry. The Director brings deep knowledge of Value, Access, Evidence and Pricing functions within the pharmaceutical industry and applies that expertise in a consultative, solutions-oriented business development approach. The role partners closely with internal scientific, strategy, creative, innovation and delivery teams to shape and close complex, high-value opportunities. Key Responsibilities Strategic Selling & Revenue Growth Position and sell Red Nucleus’s Value, Access and Evidence for large pharma and biotech organizations.Identify, qualify, and close new business opportunities using a consultative, value-driven sales approachGrow existing accounts via new product / indication launches and expansion into new business units for Red Nucleus.Engage cross-functional V&E stakeholders in support of new business initiatives and co-ordinate multi-capability pursuitsAdvance strategic client relationships that support repeat business, multi-year engagements, and long-term partnershipsLeverage deep knowledge of the pharmaceutical industry to shape differentiated client solutionsCollaborate with V&E subject matter experts to design integrated, high-impact proposalsAct as a commercially oriented domain expert in client discussions, articulating Red Nucleus’s value proposition and solution vision Enterprise Go To Market Execution Execute against the enterprise go-to-market strategy as it relates to V&E offerings such as:Global launch price and strategy and governanceCross-indication pricing strategyPrice and Access forecasting (gross to net optimization)Contracting StrategyPayer segmentation and engagement strategyOrganizational design and launch readinessMarket access analytics and patient journey analyticsCommercial and business insights Work cross-functionally with Marketing, Client Services, and Division leadership to ensure alignment on messaging, positioning, and commercial prioritiesSupport enterprise selling motions that balance near-term revenue objectives with longer-term client relationship development Pipeline Management, Forecasting & Commercial Excellence Maintain disciplined pipeline management in Salesforce, ensuring accurate forecasting, opportunity progression, and data integrityLead pricing, scoping, and solution negotiations to ensure profitable, sustainable engagementsEnsure effective handoff from business development to delivery teams, supporting high-quality client transitionsPartner with Sales Operations to monitor performance metrics, conversion rates, and pipeline health Cross-functional Collaboration & Market Presence Build strong working relationships with Global Medical Affairs division delivery leaders to support integrated solution designCollaborate with Marketing on thought leadership initiatives, campaign focus areas, and conference participationRepresent Red Nucleus at industry conferences, client meetings, and external events as a senior commercial contributor Background and Skill Requirements Bachelor’s degree required; advanced degree in Life Sciences, Business, or related field strongly preferred8+ years of experience in business development roles selling Value and Evidence services to pharmaceutical and biotech organizations with a strong focus on new business wins.Proven track record of achieving or exceeding annual revenue targets ($3–4M+)Deep experience engaging relevant pharma stakeholders responsible for hiring Value, Access and Evidence advisory service providersExperience operating effectively within a matrixed scientific, operational, and technical environmentAbility to travel up to 50%